Beleave Stock Current Valuation
Valuation analysis of Beleave helps investors to measure Beleave's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Undervalued
Today
Please note that Beleave's price fluctuation is out of control at this time. Calculation of the real value of Beleave is based on 3 months time horizon. Increasing Beleave's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Beleave pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Beleave. Since Beleave is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Beleave Pink Sheet. However, Beleave's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0 | Real 0.0 | Hype 0.0 |
The real value of Beleave Pink Sheet, also known as its intrinsic value, is the underlying worth of Beleave Company, which is reflected in its stock price. It is based on Beleave's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Beleave's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Beleave helps investors to forecast how Beleave pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Beleave more accurately as focusing exclusively on Beleave's fundamentals will not take into account other important factors: Beleave Company Current Valuation Analysis
Beleave's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Beleave Current Valuation | 5.66 K |
Most of Beleave's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beleave is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Beleave has a Current Valuation of 5.66 K. This is 100.0% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Beleave Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beleave's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Beleave could also be used in its relative valuation, which is a method of valuing Beleave by comparing valuation metrics of similar companies.Beleave is currently under evaluation in current valuation category among its peers.
Beleave Fundamentals
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 5.66 K | |||
| Shares Outstanding | 566.37 M | |||
| Price To Earning | (4.44) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 816.46 K | |||
| EBITDA | (30.76 M) | |||
| Net Income | (33.78 M) | |||
| Cash And Equivalents | 120.41 K | |||
| Debt To Equity | 2.44 % | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.47 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 27.8 | |||
| Market Capitalization | 566 | |||
| Total Asset | 23.61 M | |||
| Z Score | -3.3 | |||
| Net Asset | 23.61 M |
About Beleave Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beleave's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beleave using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beleave based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |